Clinical trial
Analysis of the Types and Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients at Erasto Gaertner Hospital, Curitiba, Brazil.
NCT03171636 is registered in ClinicalTrials.gov with Hospital Erasto Gaertner as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Types and Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients at Erasto Gaertner Hospital, Curitiba, Brazil.
- Lead sponsor
- Hospital Erasto Gaertner
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- January 31, 2019
- Enrollment
- 130 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
egfr gene mutation, kras gene mutation, lung neoplasms